Company Search:
Advanced Search
Sponsored Links
Idera Pharmaceuticals, Inc. Company Snapshot
Idera Pharmaceuticals, Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Idera Pharmaceuticals with three other companies in this sector in the United States: CEL-SCI Corporation (2018 sales of $476,556.00 ), Trovagene Inc ($378,325.00 of which 100% was Biological Product), and AIM ImmunoTech Inc ($367,000.00 ).

Sales Analysis. During the year ended December of 2018, sales at Idera Pharmaceuticals were $662,000.00 . This is a sharp decrease of 26.6% versus 2017, when the company's sales were $902,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Idera Pharmaceuticals, Inc.
  Stock Performance Chart for Idera Pharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (12/13/2019): 1.60
(Figures in U.S. Dollars)
1 Week -11.6%   13 Weeks -24.2%  
4 Weeks -49.5%   52 Weeks -59.8%  
Idera Pharmaceuticals, Inc. Key Data:
  Ticker: IDRA Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 662,000
(Year Ending Jan 2019).
Employees: 36
  Currency: U.S. Dollars Market Cap: 46,172,800
  Fiscal Yr Ends: December Shares Outstanding: 28,858,000
  Share Type: Common Closely Held Shares: 5,637,588
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.